Medicine Application (Store Near)
The pharmacy is closer than the patient thinks — we just have to map it.
India has roughly 9.5 lakh licensed retail pharmacies — one of the densest pharmacy networks on earth. Yet the e-pharmacy conversation has been dominated by warehouse-led players (1mg, PharmEasy, Apollo 24/7, Netmeds) who ship from distant fulfilment centres, often taking 12–48 hours and frequently failing on Schedule H prescription verification.
Store Near flips the model. Instead of pulling medicine demand into a central warehouse, we route it to the nearest verified neighbourhood chemist within a 2-kilometre radius. The patient gets delivery in 15–30 minutes — or walks in for pickup. The chemist gets a digital order pipeline without losing their walk-in identity.
Status: this is an idea-stage concept under evaluation. Market figures cited are addressable potential and would need validation through a Noida-NCR pilot before any capital is committed.
A medicine ordered online from a warehouse 40 kilometres away is a logistics problem. A medicine ordered from the chemist 400 metres down the road is a software problem — and it is the one India still hasn't solved.
The opportunity, on its own terms.
Quick-commerce has trained Indian consumers on 15-minute delivery.
Blinkit and Zepto proved the dark-store model for groceries, but medicines remain stuck in slow warehouse logistics — the discipline gap is the opportunity.
ABHA and digital prescriptions are live.
India's Ayushman Bharat Health Account now lets patients carry prescriptions digitally. A hyperlocal app can verify Schedule H drugs against a real digital script instead of a blurry WhatsApp photo.
Neighbourhood chemists are getting squeezed.
Online pharmacies have eaten 8–12% of urban pharma retail in five years. Local chemists need a software lifeline that lets them compete on speed instead of price.
Chronic disease is compounding demand.
India has 101 million diabetics and 220 million hypertensive patients. These are monthly repeat customers — the unit economics of subscription delivery only work if you are already 2 kilometres away.
Sized in three rings.
- Chronic refills are ~60% of pharmacy revenue — subscription delivery is the wedge.
- Indian e-pharmacy market expected to cross ₹40,000 cr by 2027 (RedSeer).
- Avg basket size on prescription orders: ₹600–900; OTC + wellness: ₹300–450.
- Schedule H compliance — a moat against unregulated WhatsApp-based pharmacy delivery.
How it works, end to end.
Chemist-first marketplace
We do not own inventory. Licensed neighbourhood pharmacies list their stock through a lightweight Android POS bridge. Orders route to the nearest available chemist with the SKU in stock — the patient pays the chemist's own MRP, not a marked-up version.
Prescription validation layer
Every Schedule H order is checked by an in-house registered pharmacist before dispatch — script verified against ABHA or uploaded image, dosage flagged, drug interactions screened. This is the regulatory firewall that warehouse e-pharma keeps failing on.
Hyperlocal logistics
A blended fleet — chemist's own delivery boys for orders under 1 km, a shared BIDUA rider pool for the 1–3 km radius. No dark stores, no inventory risk.
Revenue split
Platform fee: 8–12% commission on prescription orders, 15–18% on OTC and wellness SKUs. Subscription plan for chronic patients (₹99/month) waives delivery fee and unlocks 5% off.
Data and chronic-care upsell
Consented refill data feeds a chronic-care engine — diabetes, hypertension, thyroid. Tele-consult upsell with general physicians at ₹149 per session creates a second revenue line on top of medicine margin.
Three compounding phases.
Pilot & onboarding
- Commission on partner-chemist orders (8–12%)
- OTC and wellness margin (15–18%)
- Onboarding fee for POS bridge (₹2,500 one-time)
- Sponsored placement for generic-equivalent SKUs
Subscription & care
- Chronic-care subscription (₹99/month)
- Tele-consultation revenue share (₹149/session)
- Diagnostic lab booking commission (10–15%)
- Pharma-brand digital shelf advertising
Vertical depth
- Private-label OTC and ayurveda line
- Insurance claim integration fees
- B2B medicine supply to old-age homes & clinics
- Health-data aggregation for pharma research (consented)
Patient cadence, deliberate steps.
-
Q1 2027Validate concept — 30 in-depth interviews with NCR chemists and 200 patient surveys.
-
Q3 2027Noida pilot — 50 partner chemists, 5,000 households, single-zone test of unit economics.
-
Q2 2028NCR rollout — 500 chemists across Delhi, Gurgaon, Noida, Ghaziabad, Faridabad.
-
2029Expand to Mumbai, Bengaluru, Hyderabad. Launch chronic-care subscription.
-
2030Tele-consult and diagnostic booking go live. Target 1,500 chemists, 12 cities.
-
2031Private-label OTC line; integration with major insurers for cashless OPD pharmacy.
Who else is here — and why we're different.
- Chemist-first — we do not compete with local pharmacies, we equip them.
- Verified pharmacist review on every Schedule H order — a real compliance moat.
- 15–30 minute delivery without owning inventory or dark stores.
- Chronic-care subscription that turns one-time buyers into 36-month annuities.
What can go wrong — and how we plan for it.
Regulatory tightening on e-pharmacy
Mitigation: Stay licensed-chemist-led — we are a logistics + software layer, not the seller. Active engagement with CDSCO and state drug controllers.
Discount-led incumbents undercut commissions
Mitigation: Compete on speed and pharmacist trust, not price. Subscription locks chronic patients into the network.
Chemist adoption is slow
Mitigation: Free POS bridge, zero onboarding cost, in-language training. Onboard chemist associations city by city.
Counterfeit or expired drugs in supply
Mitigation: Batch + expiry capture at the chemist's POS. Mystery-shopping audits. Penalty & delisting policy.
Last-mile cost in monsoon / peak hours
Mitigation: Shared rider pool with delivery surcharge during peak. Pickup option always available as fallback.
Connected BIDUA divisions.
Every BIDUA bet feeds something else in the group. This one connects to:
Live
BIDUA Hosting
Cloud and ABHA-integration backbone for prescription, order and pharmacist workflows.
biduahosting.com
Live
FinWault
Subscription billing, chemist payouts, and insurance-claim settlement rails.
finwault.com
Live
BIDUA Beauty Care
Cross-sell wellness, dermatology and ayurveda SKUs through the same hyperlocal pipeline.
biduabeauty.com
Questions partners and investors actually ask.
How is this different from 1mg or PharmEasy?
Those are warehouse models — they ship from central fulfilment centres in 12–48 hours. We route every order to the nearest licensed chemist within 2 kilometres and deliver in 15–30 minutes.
Is this legal under Indian e-pharmacy rules?
Yes — because the seller of record is always a fully licensed retail pharmacy with a valid drug licence. We are the technology and logistics layer.
How do you verify prescriptions?
Every Schedule H order is reviewed by an in-house registered pharmacist. We accept ABHA-linked digital scripts and verified uploaded prescriptions.
What does the chemist have to invest?
Zero capital. We provide the Android POS bridge free of cost and absorb onboarding. The chemist pays only the platform commission on completed orders.
What is the expected commission?
8–12% on prescription medicines and 15–18% on OTC and wellness SKUs — significantly below the 25–35% margin compression that warehouse e-pharmacy forces on local stores.
When do you plan to launch?
Subject to validation, we are targeting a Noida pilot in Q3 2027 with 50 partner chemists before any NCR-wide rollout.
What about chronic care?
A ₹99/month subscription gives chronic patients free delivery, automatic monthly refills and a 5% loyalty discount. Diabetes and hypertension are the launch cohorts.
Where does BIDUA fit?
BIDUA Hosting provides the cloud and ABHA integration backbone; FinWault primitives handle subscription billing and chemist payouts.
Help us pressure-test the Store Near pilot.
We are looking for 50 founding chemists in Noida and Delhi NCR to co-design the platform. Equipment, training and onboarding are on us.